基于全基因组分析解析抑郁症病理生理、复发风险预测及共病精神障碍
抑郁症高度多基因,约11,700个变异解释90%的单核苷酸多态性遗传力;最高多基因负荷的抑郁症患者复发和共病精神障碍的绝对风险分别较最低负荷者及背景人群高至多5倍和32倍,并存在明显性别差异。
要点
- 识别243个抑郁症风险位点,其中64个为新位点,包括谷氨酸和GABA受体基因。
- 约11,700个变异解释90%的SNP遗传力,>95%的其他精神障碍风险变异影响抑郁症风险。
- 最高多基因负荷者复发风险较最低负荷者高至多5倍,较背景人群高至多32倍。
核心结论
- 抑郁症具有高度多基因性,遗传风险与复杂认知域受损相关,不同亚组具有不同的多基因结构。
主要发现
- 共识别243个风险位点,其中64个为新位点,包括编码谷氨酸和GABA受体的基因。
- 约11,700个变异解释90%的单核苷酸多态性遗传力。
- 当同时考虑一致和不一致变异时,估计>95%的其他精神障碍(焦虑、精神分裂症、双相障碍和注意缺陷多动障碍)风险变异影响抑郁症风险,几乎所有抑郁症风险变异影响教育程度。
- 抑郁症遗传风险与复杂认知域受损相关。
- 最高多基因负荷的抑郁症患者复发和共病精神障碍的绝对风险较最低多基因负荷者高至多5倍,较背景人群高至多32倍,并存在明显性别差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Depression is a common psychiatric disorder and a leading cause of disability worldwide. Here we conducted a genome-wide association study meta-analysis of six datasets, including >1.3 million individuals (371,184 with depression) and identified 243 risk loci. Overall, 64 loci were new, including genes encoding glutamate and GABA receptors, which are targets for antidepressant drugs. Intersection with functional genomics data prioritized likely causal genes and revealed new enrichment of prenatal GABAergic neurons, astrocytes and oligodendrocyte lineages. We found depression to be highly polygenic, with ~11,700 variants explaining 90% of the single-nucleotide polymorphism heritability, estimating that >95% of risk variants for other psychiatric disorders (anxiety, schizophrenia, bipolar disorder and attention deficit hyperactivity disorder) were influencing depression risk when both concordant and discordant variants were considered, and nearly all depression risk variants influenced educational attainment. Additionally, depression genetic risk was associated with impaired complex cognition domains. We dissected the genetic and clinical heterogeneity, revealing distinct polygenic architectures across subgroups of depression and demonstrating significantly increased absolute risks for recurrence and psychiatric comorbidity among cases of depression with the highest polygenic burden, with considerable sex differences. The risks were up to 5- and 32-fold higher than cases with the lowest polygenic burden and the background population, respectively. These results deepen the understanding of the biology underlying depression, its disease progression and inform precision medicine approaches to treatment.
引用
- Als TD, Kurki MI, Grove J, et al. Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. Nat Med. 2023. PMID: 37464041. doi:10.1038/s41591-023-02352-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。